Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
Response from CEO, CHAI about the Quick Start program in November 2016
Response from CEO, CHAI about the Quick Start program in November 2016
Please click here
December 21, 2016
/
News
Related
Posts
20 YEARS AFTER THE TRIPS AGREEMENT, U.S. GOVERNMENT SCORES MASSIVE VICTORY FOR BIG PHARMA IN TPP DEAL
Updated WHO screening, care and treatment of persons with hepatitis C infection_ April 2016.
Glecaprevir-Pibrentasvir Effective for Hepatitis C After Treatment Failure
Progress report on access to hepatitis C treatment, WHO March 2018
Letter from Community in Asia and Eastern Europe to Global Fund Board for Financing Hep C Treatment
BMS’ patent bid for Hep C treatment Daclatasvir Challenged
Strategies to Secure Access to Generic HCV Medicines
18 hospitals offer free DAA therapy for treatment of Hepatitis C in Malaysia